局部晚期宫癌的辅助,新辅助和手术治疗:贝叶斯网络元分析
Isadora Mamede1, Israt Jahan Riya2, Ifrat Jahan Piya2
1Federal University of São João del-Rei, Department of Medicine, Divinópolis, Brazil.
概括
同时化学放射治疗是晚期子宫癌的标准. 虽然免疫检查点抑制剂显示出前景,但并发化疗仍然是基石治疗,其疗效与其他策略相美.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 辐射疗法 辐射疗法
背景情况:
- 同时化学放射治疗是局部晚期子宫癌的标准.
- 正在探索诸如诱导化疗和免疫检查点抑制剂等替代策略.
- 需要证据来比较这些不同的治疗方式.
研究的目的:
- 进行网络元分析,比较当地晚期宫癌的各种治疗策略的疗效.
- 在不同治疗方案中评估整体存活率 (OS) 和无进展存活率 (PFS).
主要方法:
- 对局部晚期宫癌 (FIGO IB2-IVA 阶段) 随机对照试验 (RCT) 的系统审查.
- 贝叶斯网络的元分析包括并发化疗,诱导化疗,辅助化疗,单独放射治疗,免疫检查点抑制剂和手术.
- 从OS和PFS的卡普兰-梅尔曲线中提取或重建的危险比率 (HRs).
主要成果:
- 分析了47项试验 (14,155名患者). 在治疗之间没有发现OS的显著差异,尽管并发化学放射治疗趋势优于单独的放射治疗.
- 与放射疗法和诱导化学疗法相比,同时进行的化疗和放射疗法显示出更好的PFS.
- 与免疫检查点抑制剂同时进行的化疗放射治疗显示,OS和PFS的排名最高.
结论:
- 同时化学放射治疗仍然是局部晚期子宫癌的基石治疗,超过单独的放射治疗和手术.
- 较新的方法,特别是那些包含免疫检查点抑制剂的方法,显示出显著的希望,并需要进一步调查.
更多相关视频
相关概念视频
01:21Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K